¶ Enteric Nervous System - Expanded
Enteric Nervous System Expanded is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The enteric nervous system (ENS) is the "second brain" - a complex network of neurons embedded in the gut lining. It controls GI motility, secretion, and blood flow.
- Alpha-synuclein pathology in PD starts in the gut
- GI dysfunction in PD (constipation)
- Prion-like spread of alpha-synuclein
- Enteric neurons: Sensory, motor, interneurons
- Enteric glia: Support and signaling
- Enteroendocrine cells: Chemical sensing
- Myenteric plexus (Auerbach): Primary motor control
- Submucosal plexus (Meissner): Secretion, blood flow
- GI alpha-synuclein as early biomarker
- Constipation as PD risk factor
- Fecal microbiota transplantation studies
The study of Enteric Nervous System Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The enteric nervous system contains diverse neuronal types:
- Sensory neurons: Detect stretch, chemical stimuli, and luminal content
- Interneurons: Process and integrate sensory information
- Motor neurons: Control smooth muscle, secretory cells, and blood flow
- Cholinergic: Primary excitatory motor neurons
- Nitrergic (NOS): Primary inhibitory motor neurons
- Serotonergic: Modulatory interneurons
- Dopaminergic: Sensory processing
- VIPergic: Secretomotor control
- Location: Between longitudinal and circular muscle layers
- Function: Primary controller of gut motility
- Neuron density: ~20 neurons per mm²
- Ganglia: Connected in linear chains along gut
- Location: Submucosa adjacent to mucosa
- Function: Regulates secretion and blood flow
- Subdivisions: Outer (Schabadasch's plexus) and inner (Meissner's plexus)
- Sensory integration: Monitors mucosal environment
Key markers for ENS neurons:
- HuC/D: Pan-neuronal marker
- PGP9.5 (UCHL1): General neuronal marker
- nNOS: Neuronal nitric oxide synthase
- ChAT: Choline acetyltransferase
- CGRP: Calcitonin gene-related peptide
- 5-HT: Serotonin
- S100: Glial marker
- Sensors: Mechanical (stretch receptors), chemical (nutrient, pH)
- Properties: TTX-resistant action potentials
- Transduction: Piezo2 for stretch, chemoreceptors for nutrients
- Descending interneurons: Motor program inhibition
- Ascending interneurons: Peristalsis coordination
- Local interneurons: Local reflex modulation
- Excitatory: Acetylcholine, substance P
- Inhibitory: Nitric oxide, VIP
- Secretomotor: Acetylcholine to glands
- Peristalsis: Coordinated circular-longitudinal muscle contraction
- Segmentation: Mixing movements
- Migrating Motor Complexes (MMC): Housekeeping rhythm
- Defecation reflex: Rectal distention triggering
- Mucous secretion: Goblet cell activation
- Electrolyte transport: Chloride secretion
- Water flux: Aquaporin regulation
- Mucosal perfusion: Demand-responsive
- Submucosal arterioles: Neural control
- Tight junction modulation: Neural influence
- Mucosal defense: Immune modulation
- Nodose ganglion: Primary vagal sensory neurons
- NTS: Brainstem relay
- Signaling: Mechano- and chemoreceptor input
- Dorsal root ganglia: Thoracolumbar sensory neurons
- Spinal cord: Visceral pain pathways
- Hypothalamus: Homeostatic control
- Amygdala: Emotional processing
- Cortex: Conscious perception
- α-Synuclein pathology: Found in ENS of PD patients
- Gut dysfunction: Precedes motor symptoms by years
- Constipation: Common early symptom
- Braak staging: Suggests gut-origin hypothesis
- Gut microbiome changes: Altered in AD
- Blood-brain barrier: Gut-inflammatory links
- Cholinergic dysfunction: Affects gut motility
- Bulbar involvement: Swallowing dysfunction
- Autonomic dysfunction: Common in advanced disease
- Visceral hypersensitivity: Enhanced pain perception
- Motility abnormalities: Altered peristalsis
- Brain-gut axis: Dysregulated communication
- Neural inflammation: Enteric gliosis
- Pain pathways: Hyperplasia of sensory neurons
- Autonomic dysregulation: Alters immune function
- Enteric neuropathy: Severe motility failure
- Myopathy: Muscle layer involvement
- Treatment: Prokinetics, surgery
- Aganglionosis: Absent ENS neurons
- RET mutations: Primary genetic cause
- Surgical resection: Treatment of choice
- 5-HT4 agonists: Enhance motility (prucalopride)
- Mu-opioid antagonists: Treat constipation (naloxegol)
- Guanylate cyclase agonists: Secretion (linaclotide)
- Probiotics: Restore healthy microbiota
- Fecal transplantation: For C. difficile, IBS
- Dietary interventions: Prebiotic fibers
- Vagus nerve stimulation: Modulate gut-brain axis
- Sacral nerve stimulation: For fecal incontinence
- Transcutaneous vagal stimulation: Experimental
- Stem cell therapy: Replace lost neurons
- Gene therapy: RET, GDNF delivery
- Enteric glia modulation: Neuroprotection
- Furness et al., Enteric nervous system: Comprehensive review (2020)
- Gershon et al., The enteric nervous system in gastrointestinal disorders (2019)
- Costa et al., Neural circuits of the enteric nervous system (2020)
- Braak et al., Parkinson's disease and gut (2021)
- Rao et al., Irritable bowel syndrome and brain-gut axis (2020)
- Hyland et al., Enteric glial cells in neurodegeneration (2021)
- Mayer et al., Gut-brain axis and neurological disorders (2020)
- Brierley et al., Gut sensory transduction (2021)